Search

everythinglearnresearchcommunity

for

Search:↓

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Monitoring for adverse effects in clinical treatments is crucial.

High doses of certain vitamins can cause serious side effects and health risks.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

High mTORC1 activity slows hair growth and causes it to lose color.

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

The cat's hypothyroidism was successfully managed with levothyroxine, leading to a stable condition.

Changing neuroactive steroid levels early in life can affect how adult rats respond to alcohol's stimulating effects.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Sodium valproate can cause reversible hair loss in some patients.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

Timely diagnosis of SLE is crucial due to symptom overlap with fibromyalgia.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Sodium valproate is not recommended as a first-line treatment for neuropathy but may be used in resistant cases.

Early over-expression of FoxN1 harms immune and skin development.

Some generic finasteride may be counterfeit, leading to less effectiveness and increased hair loss.

Certain vitamins in wrong amounts, alcohol abuse, metals, and other toxins can cause serious brain and nerve damage.